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Abstract Intracellular calcium is a second messenger involved
in several processes in yeast, such as mating, nutrient sensing,
stress response and cell cycle events. It was reported that glucose
addition stimulates a rapid increase in free calcium level in yeast.
To investigate the calcium level variations induced by different
stimuli we used a reporter system based on the photoprotein
aequorin. Glucose addition (50 mM) to nutrient-starved cells
induced an increase in free intracellular calcium concentration,
mainly due to an influx from external medium. The increase of
calcium reached its maximum 100^120 s after the stimulus. A
concentration of about 20 mM glucose was required for a 50%
increase in intracellular calcium. This response was completely
abolished in strain plc1v and in the isogenic wild-type strain
treated with 3-nitrocoumarin, a phosphatidylinositol-specific
phospholipase C inhibitor, suggesting that Plc1p is essential
for glucose-induced calcium increase. This suggests that Plc1p
should have a significant role in transducing glucose signal. The
calcium influx induced by addition of high glucose on cells
previously stimulated with low glucose levels was inhibited in
strains with a deletion in the GPR1 or GPA2 genes, which
suggests that glucose would be detected through the Gpr1p/
Gpa2p receptor/G protein-coupled (GPCR) complex. Moreover,
the signal was completely abolished in a strain unable to
phosphorylate glucose, which is consistent with the reported
requirement of glucose phosphorylation for GPCR complex
activation. - 2002 Published by Elsevier Science B.V. on be-
half of the Federation of European Biochemical Societies.
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1. Introduction
Eukaryotic cells use calcium as a second messenger in sev-
eral relevant signal transduction pathways, e.g. exocytosis,
response to growth factors, synaptic activity, etc., and in
many of these processes intracellular calcium increases as a
consequence of the activation of polyphosphoinositide turn-
over (PI turnover), which in turn is regulated by the activity
of phosphoinositide-speci¢c phospholipases C (PLC) [1,2].
There is increasing evidence that the intracellular calcium
level plays a regulatory role also in the budding yeast Saccha-
romyces cerevisiae. In fact, variations of intracellular calcium
have been observed during mating [3,4], hypotonic stress [5,6],
after addition of glucose to glucose-starved cells [7^10], and
during some cell cycle events [11^14]. The inhibition of cal-
cium-dependent processes (for example through the addition
of calmodulin inhibitors) always causes an immediate growth
inhibition [11], suggesting that calcium plays a role as a rele-
vant second messenger also in yeast. Moreover, the intracel-
lular calcium level appears to be tightly controlled; yeast cells
contain huge amounts of calcium that is con¢ned in cellular
compartments (vacuoles, mitochondria, etc.) while the free
cytoplasmic calcium concentration is very low, around 200^
300 nM [3,9,15,16].
S. cerevisiae Plc1p is a phosphatidylinositol (PI)-speci¢c
PLC with high homology to the mammalian PLC N isoform
[17^19] that was shown to be essential for glucose-stimulated
PI turnover and subsequent activation of plasma membrane
Hþ-ATPase [20]. Deletion of the Plc1p-encoding gene (PLC1)
causes a pleiotropic phenotype including defects in the utilisa-
tion of carbon sources di¡erent from glucose, as well as sen-
sitivity to osmotic stress and high temperature. The severity of
this phenotype is strictly dependent on the genetic background
[17^19].
The PI turnover pathway is well known in mammalian cells,
where it leads to activation of protein kinase C directly by
diacylglycerol and by inositol triphosphate through calcium
release from intracellular stores [2]. A protein kinase C also
exists in yeast, where it is involved in maintenance of cell
integrity both during stress response to hypotonic downshift,
heat shock or nutrient starvation, and during bud generation
or cellular di¡erentiation, through activation of a mitogen-
activated protein (MAP) kinase cascade [21]. Despite the sim-
ilarity with mammalian PI turnover, there is no direct evi-
dence of Plc1p involvement in Pkc1p activation. Stress sensi-
tivity phenotypes observed in both plc1v and pkc1 mutants
suggest a possible link, but no genetic interactions have been
reported which support this model. Up to now, the only iden-
ti¢ed role of Plc1p is in transducing glucose signalling, which
is consistent with reported data about the physical interaction
of Plc1p with a G protein-coupled receptor, Gpr1p, involved
in glucose sensing [22].
It was initially suggested that the Gpr1p/Gpa2p G protein-
coupled receptor (GPCR) system was involved in nitrogen
sensing [23], but recently it was shown that this system is
also required for activation of cAMP synthesis by glucose
[24]. In addition to Gpr1p and Gpa2p, glucose activation of
cAMP synthesis also requires uptake and phosphorylation of
the sugar [25,26].
It was reported that both hypotonic shock and glucose
addition stimulate a rapid increase in free calcium level [5].
In order to clarify if Plc1p is required for these responses, we
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investigated the e¡ect of deprivation of Plc1p activity, either
by a PLC1 gene deletion or by protein inactivation through a
PI-PLC-speci¢c inhibitor, 3-nitrocoumarin, which was previ-
ously proved to be very e⁄cient and selective for the yeast
enzyme [27].
2. Materials and methods
2.1. Yeast strains, plasmids, growth conditions and transformation
The wild-type strain WPY260 (MATK ura3-52 his3-11,15 trp1-v901
ade2-101) and the isogenic mutant WPY300 (plc1: :URA3) were
kindly provided by M. Fitzgerald-Hayes (Amherst). The W303-1B
(MATK leu2-3,112 ura3-1 trp1-92 his3-11,15 ade2-1 can1-100 GAL
SUC mal) and its derivatives gpr1v : :LEU2, gpa2v : :LEU2 and
YSH758(a) (hxk1 :HIS3, hxk2 : :LEU2, glk1 : :LEU2) were from the
Laboratory of J.M. Thevelein (KU Leuven, Belgium). The W303
strain carrying the multicopy plasmid pWP101, containing the
PLC1 coding sequence, was previously described [20]. The W303-1A
strain containing the pG2CT-112.2 plasmid [23], a multicopy plasmid
carrying the constitutive GPA2R273A allele, was kindly provided by J.
Winderickx (KU Leuven, Belgium).
The integrative expression vector pYX012 (Ingenius) was modi¢ed
to generate the pYX012-G418R plasmid by inserting in SmaI site the
SmaI^EcoRV KanMX4 cassette from plasmid pFA6a [28]. The ae-
quorin coding sequence was excised from plasmid cytAEQ/pCDNAI
(Molecular Probes) by cutting with EcoRI and insertion in the EcoRI
site in pYX012, in pYX012-G418R or in pYX212 to generate respec-
tively pYX012-AEQ, pYX012-cytAEQ-G418R or pYX212-AEQ.
Strains WPY260 and WPY300 were transformed with the integra-
tive expression vector pYX012-cytAEQ-G418R, while W303 and its
derivatives were transformed with the multicopy vector pYX212-cyt-
AEQ.
Yeast transformation was performed by a modi¢ed lithium acetate
method [29] and Uraþ transformants were selected for growth on
synthetic complete medium lacking uracil, that is 2% glucose, 2%
agar, 0.67% yeast nitrogen base (Difco), 0.77 g/l CSM3ura (Complete
Synthetic Medium supplied by Bio-101, CA, USA, containing every
amino acid and adenine). For selection for G418 resistance trans-
formed cells were ¢rst incubated in liquid rich medium (YPD, con-
taining 2% glucose, 2% tryptone and 1% yeast extract by Biolife,
USA, supplemented with 50 mg/l adenine and tryptophan) at 24‡C
for about 16 h and then plated on solid YPD medium supplemented
with 100 Wg/ml G418 (Geneticin, Gibco BRL). For luminescence as-
says yeast cells were grown in £asks on rich medium (YPD) in a
Dubno¡ shaking incubator at 24‡C.
2.2. In vivo monitoring of cytosolic free calcium concentration after
nutrient starvation
Exponentially growing cells (5^6U106 cells/ml) in liquid rich me-
dium (YPD), or in YPGal (containing 2% galactose, 2% tryptone and
1% yeast extract) if indicated, at 24‡C were harvested by ¢ltration on
nitrocellulose ¢lters (Millipore; pore size 0.45 Wm), washed three times
with water (1 volume/wash) and resuspended in 0.1 M 2-(N-morpho-
lino)ethanesulphonic acid (MES)/Tris, pH 6.5 (MES/Tris bu¡er) at a
density of about 1U108 cells/ml. Cells were incubated for 1.5 h at
24‡C, collected by centrifugation at 3500 rpm for 2 min at room
temperature and resuspended in the same nutrient-free bu¡er
(2.5U109 cells/ml). To reconstitute functional aequorin, 50 WM coe-
lenterazine (Molecular Probes; stock solution 1 Wg/Wl dissolved in
methanol) was added to 30 Wl of the cell suspension and the cells
were incubated for 20 min at 24‡C, in the dark. Excess coelenterazine
was removed by washing cells three times with 0.1 M MES/Tris bu¡er
(pH 6.5) (200 Wl/wash) by centrifugation at 6000 rpm for 2 min at
room temperature. 500 Wl of the cell suspension (5U107 cells/ml in 0.1
M MES/Tris bu¡er) was transferred to a luminometer tube and 10
mM CaCl2 (¢nal concentration) was added (or omitted where indi-
cated). Glucose or other carbon sources were added to give the ¢nal
concentrations indicated in the text and light emission was monitored
with a Berthold Lumat LB 9501/16 luminometer for at least 6 min
after the stimulus, at 6-s intervals and reported in relative lumines-
cence units/s (RLU/s). The ¢gures shown represent typical lines that
were reproduced in at least three di¡erent experiments.
The e¡ect of 3-nitrocoumarin on glucose-induced calcium pulse was
tested by further incubating the coelenterazine-loaded cell suspension
with the inhibitor (¢nal concentration 50 Wg/ml; stock solution dis-
solved in dimethylsulphoxide (DMSO) and stored at 320‡C) for 15
min at room temperature, in the dark, before adding glucose. Cells
treated with the same amount (% w/v) of DMSO were used as a
control. The 3-nitrocoumarin was synthesised as described previously
[27].
The calcium chelator BAPTA (tetrapotassium salt, Sigma; stock
solution 10 mM dissolved in 0.1 M MES/Tris pH 6.5) was added to
the cell suspension at a ¢nal concentration of 1 or 0.5 mM 3 min
before the addition of glucose.
At the end of each experiment aequorin expression and activity
were tested by lysing cells with 0.5% Triton X-100 or by adding the
calcium ionophore A23187 (10 WM) (Calcimycin, free acid; Sigma).
2.3. In vivo monitoring of hypotonic shock-induced calcium pulse
Aequorin-expressing cells were grown in rich medium (YPD) at
24‡C until the mid-exponential phase (6^7U106 cells/ml) and then
collected by centrifugation at 3500 rpm for 5 min, at room temper-
ature. The cell pellet was resuspended in fresh rich medium (YPD) at
a density of 2.5U109 cells/ml. 30 Wl of the cell suspension was incu-
bated with coelenterazine as described above. After three washes with
fresh YPD medium (200 Wl/wash) by centrifugation at 6000 rpm for
2 min at room temperature, cells (7.5U107 for each treatment) were
resuspended in 100 Wl of the same medium and incubated for 5 min at
room temperature before being shocked with 400 Wl distilled water.
Aequorin-dependent light emission was monitored over a 3-min peri-
od following the stimulus, at 3-s intervals. 3-Nitrocoumarin (50 Wg/ml)
or DMSO was added to coelenterazine-loaded cells as described
above, before hypotonic shock.
2.4. Calibration of aequorin-dependent light signal
The raw data obtained from the luminometer were recorded and
transferred to a personal computer for analysis. [Ca2þ]i (cytosolic free
calcium concentration) was evaluated from the ratio of aequorin light
intensity of the yeast cells to maximum light intensity, calculated from
total light yield obtained by lysing cells with 0.5% Triton X-100 at the
end of the experiment, using a standard curve reported in the liter-
ature [30]. The Ca2þ-independent luminescence of cells carrying the
corresponding empty vector was subtracted as blank value from all of
the other data.
3. Results
3.1. The glucose-induced calcium increase is dependent on
Plc1p
A reporter system was used to investigate the calcium level
£uctuations, based on the calcium-dependent photoprotein
aequorin [9]. Apoaequorin expression was obtained by cloning
the corresponding cDNA under the TPI constitutive promoter
in di¡erent yeast vectors as described in Section 2. The func-
tional protein was reconstituted by adding its cofactor, coe-
lenterazine, in the medium. Aequorin expression and activity
were detected by bioluminescent assays, either testing its re-
sponsiveness to the cytosolic calcium level variation induced
by a calcium ionophore or verifying its abundance by the total
light emission obtained after lysing cells with a detergent,
which exposes the aequorin protein to saturating calcium con-
centrations.
Glucose addition to nutrient-starved cells induced a calcium
increase that reached its maximum within 100^120 s after the
stimulus (Fig. 1), consistent with previously reported data [7^
9]. According to the described calibration method, the light
emission obtained indicates a calcium basal level of 300^500
nM, while the calcium increase reaches a concentration of 2^3
WM.
This peak was reproducible with the aequorin system in
both wild-type strains utilised, WPY260 (Fig. 1) and W303
(Fig. 4). In contrast, the response was completely abolished in
the plc1v strain (WPY300) (Fig. 1A). Additionally, glucose
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could not induce a calcium in£ux in the WPY260 wild-type
strain when it was previously treated with 50 mg/l 3-nitro-
coumarin, a concentration that is enough to completely inhib-
it the Plc1p-dependent glucose-induced PI turnover stimula-
tion in vivo [27]. Moreover, in a strain carrying a multicopy
plasmid containing the PLC1 gene the calcium increase was
higher than in the corresponding wild-type cells, which is par-
ticularly evident when cells are stimulated with low concen-
trations of glucose (Fig. 1B). These observations indicate that
Plc1p is essential for glucose-induced calcium increase.
In order to characterise this Plc1p-dependent response to
glucose, we detected cytoplasmic calcium levels after addition
of di¡erent concentrations of glucose. We found that a con-
centration of 15^20 mM glucose was required for a 50% in-
crease in glucose-induced calcium pulse (apparent Km) (Fig.
2). Interestingly, this apparent Km value is in the same range
of that reported for cAMP signalling [25].
Total absence of calcium in the medium greatly inhibits the
glucose-induced calcium peak (Fig. 3). Exposure to BAPTA,
an extracellular Ca2þ chelator, gives the same result, apart
from a slightly higher light emission probably due to an aspe-
ci¢c luminescence increase. These data suggest a major con-
tribution of calcium in£ux from the external medium, though
they cannot exclude a requirement for the signal elicited by
calcium uptake to trigger calcium release from intracellular
sources, i.e. through opening of a calcium-sensitive channel
in the internal compartments.
The addition of other fermentable sugars di¡erent from
glucose, such as fructose or mannose, induced a lower in-
crease in cytoplasmic calcium concentration (Fig. 4A), while
other carbon sources, such as galactose, ra⁄nose, maltose and
glycerol, have no e¡ect (data not shown).
Unlike for glucose-induced calcium £ux, both fructose (Fig.
4B) and mannose (data not shown) can induce a slight cal-
cium rise also in the plc1 : :URA3 strain. Therefore, Plc1p
requirement is highly speci¢c for glucose signalling, and not
for detection of general fermentable carbon sources.
3.2. The high-glucose-induced calcium in£ux requires Gpr1p
and Gpa2p
In order to identify other components of the Plc1p-medi-
ated signalling pathway, we investigated the glucose-induced
calcium response in mutant strains lacking some proteins in-
volved in nutrient-triggered signal transduction systems.
The Gpr1p/Gpa2p GPCR system is required for full acti-
vation of cAMP synthesis by high glucose concentrations.
Pre-addition of 5 mM glucose can abolish high-glucose-in-
duced cAMP production in the gpr1v or gpa2v mutants. In
fact, the initial low glucose addition does not activate the
GPCR complex but is able to stimulate production of glucose
6-phosphate via the hexokinase system, which is a prerequisite
for Gpr1p/Gpa2p activation. The addition of a high glucose
concentration elicits the response transduced by the GPCR
complex, which is abolished by deletion of either GPR1 or
GPA2 [26]. In order to ¢nd out if the calcium signal was
GPCR-dependent, we performed similar experiments measur-
ing cytosolic calcium levels.
High glucose concentrations can induce a second calcium
in£ux in a wild-type strain previously treated with low glucose
(Fig. 5), even if the second signal is lower probably due to the
activity of the recovery systems (calcium transporters are ac-
tivated to reduce calcium concentration in the cytosol) [31].
As observed for the cAMP spike, also the calcium peak is
induced by low glucose concentrations either in the wild-type
or in both mutants, but pre-addition of 5 mM glucose com-
pletely inhibited the 100 mM glucose-induced calcium signal
in the gpr1v and gpa2v strains (Fig. 5). This suggests that the
GPCR complex is also involved in the calcium signal related
to glucose sensing; this observation is consistent with the data
reporting a physical and genetic interaction between Plc1p
and Gpr1p receptor [22].
It is known that Gpr1p/Gpa2p activation is not the only
requirement for cAMP signalling. In fact, it is necessary that
glucose must be phosphorylated to allow activation of the
adenylate cyclase [25,26]. To establish if glucose phosphory-
lation is also required for calcium signalling, we tested a
strain, YSH758(a), which lacks both of the two hexokinases
(hxk1v and hxk2v) and the glucokinase (glk1v). Addition of
glucose on this strain does not induce any increase in cyto-
plasmic calcium levels (Fig. 6). This indicates that glucose
phosphorylation is required for signal transduction through
Fig. 1. A: Coelenterazine-treated apoaequorin-expressing cells were
starved for all nutrients for 2 h, then 25 mM glucose was added at
time zero and bioluminescence was monitored for 6 min. F,
WPY260 wild-type strain; E, WPY260 exposed to 0.001% DMSO;
O, WPY260 treated with 50 mg/l 3-nitrocoumarin; R, WPY300
(plc1v strain). B: Coelenterazine-treated apoaequorin-expressing cells
were starved for all nutrients for 2 h, then glucose 5 mM was added
and bioluminescence was monitored for 6 min. R, W303 (wild-type
strain); O, W303 carrying the multicopy plasmid pWP101, encoding
Plc1p.
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the Gpr1p/Gpa2p system not only for cAMP generation but
also for calcium in£ux.
3.3. Hypotonic shock
In mammalian cells, PLC activity leads to activation of
protein kinase C. Since in yeast there are only one PI-speci¢c
PLC and one protein kinase C, it was tempting to look for a
link between the Plc1p and Pkc1p pathways. In yeast Pkc1p
activates a MAP kinase cascade pathway that is induced by
di¡erent kinds of stress, one of which is hypotonic shock [32].
Consequently, we wondered if the hypotonic shock-triggered
calcium in£ux could also be Plc1p-dependent. In order to
investigate this, we monitored the calcium levels after hypo-
tonic shock in the wild-type strain WPY260 and in the plc1v
strain WPY300. A fast response was observed both in the
wild-type strain and in the plc1v strain. Surprisingly, the cal-
cium increase was even higher in this latter than in the wild-
type strain (Fig. 7). This does not exclude an involvement of
Plc1p in the regulation of this pathway, but Plc1p is certainly
not required for the transduction of the hypotonic stress sig-
nal.
4. Discussion
The PLC1-encoded PLC was suggested to act in a signal-
Fig. 2. Coelenterazine-treated apoaequorin-expressing cells were starved for nutrients for 2 h, then, at time zero, di¡erent concentrations of glu-
cose were added as indicated below. Bioluminescence was monitored for 6 min. b, 80 mM; 8, 50 mM; R, 25 mM; a, 10 mM; 7, 5 mM;
O, 2 mM. b: Total emission was expressed as percentage of the higher emission, obtained with 80 mM glucose.
Fig. 3. Coelenterazine-treated apoaequorin-expressing cells were
starved for nutrients for 2 h and 25 mM glucose was added at time
zero. Glucose-induced calcium in£ux was observed in WPY260 cells
resuspended in MES/Tris bu¡er (b), in MES/Tris bu¡er supple-
mented with 10 mM CaCl2 (F) or with 0.5 mM BAPTA (R).
Fig. 4. Coelenterazine-treated apoaequorin-expressing cells were
starved for nutrients for 2 h, then 50 mM of di¡erent fermentable
sugars were added and bioluminescence was monitored for 6 min.
A: W303 wild-type challenged with 50 mM: 7, glucose; O, fruc-
tose; a, mannose. B: 50 mM fructose was added at time zero. R,
WPY260 wild-type cells, O, WPY300 plc1v cells.
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ling pathway triggered by glucose leading to activation of the
plasma membrane Hþ-ATPase [20].
Our data on glucose-induced calcium signalling con¢rm a
role for Plc1p activity in transducing signal after glucose stim-
ulation, and this role is speci¢c for glucose, since other sugars
(such as fructose and mannose) can still raise a calcium in£ux
even in the absence of an active Plc1p. Even if the absence of
Plc1 causes a strong reduction in the Ca2þ signal induced by
fructose, the presence of this small signal indicates that there
is at least another mechanism that can trigger calcium con-
centration variations upon nutrient signalling independently
of Plc1p activity. One possibility is that the calcium concen-
tration increase is due to a transient cytosolic acidi¢cation.
However, this is excluded by our results obtained with other
carbon sources that when added to nutrient-deprived cells
cause intracellular acidi¢cation (e.g. glycerol) [8], without
any calcium level variation (data not shown). Otherwise, the
calcium increase could be in£uenced by oscillations in ATP
levels. Anyway, no simple correlation was observed between
the variations of these two parameters [7].
The results we obtained with BAPTA, a non-permeable
calcium chelator, indicate that the major component of the
calcium £ux comes from the external medium, while a minor
contribution comes from the internal stores. It has been re-
ported that glucose induces both an in£ux from the external
medium and an e¥ux from internal stores [33]. However, this
was observed after longer times of stimulation with glucose
(20^30 min instead of 3^5 min), and so probably involved a
completely di¡erent phenomenon.
The Gpr1/Gpa2 complex activates cAMP signalling after
glucose (but not fructose) addition to derepressed cells [26].
Low concentrations of glucose added prior to high glucose
stimulation could inhibit the response to high glucose in the
gpr1v or gpa2v mutants, but not in the wild-type strain
[26,34]. The same pattern was observed for intracellular cal-
cium increase, suggesting that glucose signal can be trans-
Fig. 5. Coelenterazine-treated apoaequorin-expressing cells were starved for all nutrients for 2 h, then ¢rst 5 mM glucose at time zero and after
6 min 50 mM (as indicated by the arrow) were added. Bioluminescence was monitored as described. 8, W303 wild-type strain; a, gpr1v
strain; O, gpa2v strain.
Fig. 6. Coelenterazine-treated apoaequorin-expressing cells were
grown in YPGal, starved for all nutrients for 2 h, then 100 mM
glucose was added at time zero. Bioluminescence was monitored as
described. 8, W303 wild-type strain; 7, hxk1v hxk2v glk1v strain.
Fig. 7. Coelenterazine-treated apoaequorin-expressing cells were re-
suspended in YPD medium and then diluted with four volumes of
distilled water at time zero. Bioluminescence was monitored for
2 min. b, WPY260 wild-type strain; R, WPY300 (plc1v strain).
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duced in at least two di¡erent ways, one of which is dependent
on the Gpr1p/Gpa2p complex. It was suggested that the initial
answer to low glucose concentration would not be dependent
on Gpr1p/Gpa2p complex: in fact, this complex seems not to
be signi¢cantly activated at glucose concentrations lower than
20 mM [26], which are of the same order as the apparent Km
we found for the calcium response. Even though di¡erent
possibilities have been suggested (intracellular acidi¢cation,
hexokinase activity or glucose transporters acting as sensors),
the signalling mechanism that is supposed to act at lower
concentrations of glucose is still unknown [22,26,34]. Anyway,
unlike GPR1 or GPA2 deletions, deletion of the hexokinase-
and the glucokinase-encoding genes can arrest the glucose
signal transduction through both of these systems.
It has been proposed that Plc1p would be required to allow
an interaction between Gpr1p and Gpa2p [22]. If that was the
only role of this protein, one would expect the gpr1v and
gpa2v strains to have a phenotype as severe as the plc1v
strain, and that is not the case: deletion of GPR1 or GPA2
genes does not abolish the low glucose-induced calcium signal,
which is totally absent in the plc1v strain. Moreover, a con-
stitutive allele of GPA2, GPA2R273A, would be expected to
bypass the requirement of an active Plc1p to generate the
calcium signal. In contrast, even a multicopy plasmid carrying
that allele is not able to rescue 3-nitrocoumarin inhibition of
the calcium response (data not shown). This evidence suggests
instead a model that proposes a role for the GPCR system
acting immediately upstream of Plc1p, while the hexokinase
system would act upstream of both GPCR system and Plc1p.
Another possibility would be that Plc1p could be involved in
the generation of the hexokinases system, which might also
explain why deletion of PLC reduces the fructose-induced
Ca2þ signal. A consequence of Plc1p requirement for hexoki-
nase system activation would be that also cAMP signalling
would require Plc1p activity, and that is not the case, since
cAMP signalling is normal in the plc1v strain (K. Lemaire,
unpublished data).
Finally, our data on hypotonic shock-induced cytosolic cal-
cium in£ux indicate that this is not dependent on Plc1p. This
calcium uptake was suggested to be dependent on a stretch-
activated channel [5]. Since calcium concentration increase is
higher in the plc1v strain than in the wild-type strain, it is
possible that Plc1p could be involved in the down-regulation
of the response. Anyway, these data exclude a general require-
ment of Plc1p for calcium channel activity, suggesting that
Plc1p involvement is very speci¢c for glucose-induced calcium
£ux.
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